Xue Jun Su
Direttore/Membro del Consiglio presso SSY GROUP LIMITED
Patrimonio netto: 15 M $ in data 31/05/2024
Posizioni attive di Xue Jun Su
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SSY GROUP LIMITED | Direttore/Membro del Consiglio | 15/12/2014 | - |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Direttore/Membro del Consiglio | 07/01/2007 | - |
Storia della carriera di Xue Jun Su
Precedenti posizioni note di Xue Jun Su
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Shijiazhuang No 1 Pharmaceutical Factory | Corporate Officer/Principal | 01/01/1990 | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Direttore/Membro del Consiglio | 01/01/2002 | - |
| Presidente | - | - | |
| Corporate Officer/Principal | 01/01/2002 | - |
Formazione di Xue Jun Su
| Hebei Normal University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Cina | 4 |
| Hong Kong | 2 |
Posizioni
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chairman | 1 |
Settori
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Shijiazhuang No 1 Pharmaceutical Factory |
- Borsa valori
- Insiders
- Xue Jun Su
- Esperienza
